One Banana Presents Its Sustainability Report 2020
21.7.2021 23:27:00 EEST | Business Wire | Press release
One Banana, the better banana Co., presents its seventh Corporate Sustainability Report reflecting on the achievements and execution of its Sustainability Strategy amid a life-changing year in 2020.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210721005928/en/
Amid a life-changing year, One Banana presents its 7th Corporate Sustainability Report reflecting on the achievements made in the execution of its Sustainability Strategy in 2020. With new projects and continuing existing ones, One Banana aims to promote the well-being of customers, workers, their families, and communities through continuous improvement, environmental conservation, education, health and nutrition projects, among others. (Photo: Business Wire)
"We have taken more time, effort, and resources to prepare and publish our sustainability report due to the implementation of new methodologies to better measure and present how we create sustainable value," said Javier Aguirre, Corporate Director of AgroAmerica. "In this challenging year, we updated the pillars of our Corporate Sustainability Strategy to align business priorities and the changing expectations of our stakeholders."
One Banana and One Banana Ingredients are the brands under which AgroAmerica commercializes bananas and natural ingredients. This year, the corporation consolidated the banana ingredients business, reducing waste to a minimum and offering its customers a new range of sustainable food.
Some outstanding achievements are:
- 186 million bananas transformed into food ingredients under the principle of zero waste.
- Employment generation for 12,537 direct and indirect positions, promoting gender equality and growth opportunities for employees, their families, and communities.
- Responsible use of natural resources through investment in technology that allows a reduction of up to 50% in water use compared to traditional irrigation technologies.
- 11 international certifications, supporting the statement: We strive to achieve sustainable production every day.
- Unprecedented efforts to address the COVID-19 pandemic and extraordinary response to two hurricanes in the Central American region.
- Continuity of existing projects regarding environmental conservation, education, health and nutrition, among other projects to promote the well-being of workers, their families, and communities in the area of influence, as well as support for community management activities.
“We are pleased to present our Sustainability Report to our customers, suppliers, certifying entities, and the general public,” said Fernando Bolaños, CEO of AgroAmerica. “It reflects our commitment to do responsible business and align our corporate management with the Sustainable Development Goals while complying with the Communication on Progress (CoP) before the United Nations Global Compact, an entity of which we have been a signatory since 2020.”
This report reaffirms the corporation’s commitment to producing food and ingredients responsibly and sustainably.
"Our report notes the progress we have made and sets our expectations for the future," said Robert Adams, President of One Banana. "allowing One Banana to be the better banana Co.”,
View full report here.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210721005928/en/
Contact information
Javier Aguirre
Corporate Director
sustainability@agroamerica.com
(502) 2420-9600
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
KATE Launches "KABUKE: Break Convention" Kabuki-Inspired International Campaign17.7.2026 10:00:00 EEST | Press release
Global cosmetics brand KATE launched “KABUKE: Break Convention,” a new international campaign drawing on elements of Kabuki, the traditional Japanese performing art. The campaign debuted on Wednesday, July 8, 2026. In this campaign, KATE’s shadow enhancing makeup—rooted in Japanese aesthetics—was paired with the Kabuki spirit inherited from traditional Kabuki theater to communicate the value of individuality and self‑expression through makeup on a global scale. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708829427/en/ KATE international campaign “KABUKE: Break Convention” key visual. Dedicated website: https://www.kate-global.net/my/special/kate_kabuki/ Since its founding, KATE has championed the slogan “NO MORE RULES.,” offering makeup that defies convention and empowers individuals to express their identity and bring out confidence. At the heart of this vision is the brand’s signature shadow enhancing makeup approach
Yoshihiro Shimamura Joins the Marché du Film’s “Investors Circle 2026” as an Invited Investor, Backing a New Feature Film17.7.2026 04:00:00 EEST | Press release
Shimamura Yoshihiro Film Production Co., Ltd. (Head office: Osaka, Japan; Representative Director: Yoshihiro Shimamura), a company active in film production and investment, today announced that Representative Director Yoshihiro Shimamura has decided to invest in an international feature film after being invited to the “Investors Circle 2026” — a distinction that reflects his standing as one of the field’s most highly regarded producers and investors. Hosted by the Marché du Film, the business arm of the Festival de Cannes and one of the world’s largest film markets, the Investors Circle is an invitation-only summit that connects a select group of private investors with high-end feature films during early-stage financing. Held in Cannes, France, May 16-17, 2026, it brings internationally acclaimed directors and producers together with investors around a curated slate of projects in development. During the summit, Shimamura attended private pitching sessions and, after individual meeting
Meiji Seika Pharma: Results from the Global Phase III Trial (Integral-2) of Nacubactam, a Novel β-Lactamase Inhibitor, Highlighted in The Lancet Microbe ’s Coverage of ESCMID Global Congress 202617.7.2026 04:00:00 EEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Toshiaki Nagasato) today announced that results from the global Phase III trial (Integral-2) of nacubactam (Development Code: OP0595), a novel β-lactamase inhibitor, were highlighted in The Lancet Microbe’s coverage of ESCMID Global Congress 2026 (held in Munich, Germany). As highlighted in The Lancet Microbe’s coverage, the key findings presented by Meiji Seika Pharma at ESCMID Global Congress 2026 are as follows: The Integral-2 study (jRCT2031230076) is a global Phase III clinical trial that enrolled patients with complicated urinary tract infections, acute uncomplicated pyelonephritis, hospital-acquired bacterial pneumonia, ventilator-associated bacterial pneumonia, or complicated intra-abdominal infections caused by carbapenem-resistant Gram-negative bacteria (excluding Acinetobacter species). The study has achieved the prespecified study objectives. For the primary endpoint of overall treatme
Takeda’s Zasocitinib Demonstrates Consistent, High Rates of Skin Clearance Across the Body, Including Hard-to-Treat and High-Impact Sites, in Phase 3 Psoriasis Studies17.7.2026 01:00:00 EEST | Press release
Takeda (TSE:4502/NYSE:TAK) announced new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279), a next-generation, highly selective and potent oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented at the 2026 American Academy of Dermatology (AAD) Innovation Academy, these secondary endpoint data show that zasocitinib demonstrated consistent and high rates of skin clearance across hard-to-treat, high-impact sites, including the scalp, nails, palms and soles, compared with placebo.1-5 These data build on the topline results from the Phase 3 randomized, multicenter, double-blind, placebo- and active comparator-controlled LATITUDE PsO 3001 and 3002 studies.2,6 In those studies, about 70% of patients treated with zasocitinib achieved static Physician Global Assessment (sPGA) 0/1 (clear or almost clear skin) at week 16, with a significantly greater Psoriasis Area and Severity Index (PASI) 75 response rate seen as early as w
Merz Completes Inaugural €450 Million Schuldschein Loan Issuance17.7.2026 00:36:00 EEST | Press release
The Merz Group has successfully completed its first-ever Schuldschein loan issuance, placing a total volume of €450 million in the debt capital market – a multiple of three relating to the launch volume. The debut transaction was significantly oversubscribed and attracted strong interest from all investor groups. The proceeds were settled and paid out today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260716926041/en/ Dr. Almuth Steinkühler, Chief Financial Officer Merz Group The transaction comprises both fixed- and floating-rate tranches with maturities of three, five, seven, and ten years. Around 50 German and international investors participated, representing a broad range of institutions, including private banks, German federal state-owned banks, public savings banks, cooperative banks, pension funds and occupational pension institutions. With the successful placement, Merz has further diversified its funding base by
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom